Research to Evaluate Efficiency in U-health Solution Service for the Chronic Wound Management

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-07-31

Study Completion Date

2012-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial is a prospective research to evaluate efficiency in U-health solution service based on Mobile for the chronic wound management.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

KT(KT Corporation)-SNUBH(Seoul National University Bundang Hospital) U-health Cooperative Research

NCT02385942

Pressure Ulcer

COMPLETED NA

The Role of Telemedical Monitoring in Diabetic Foot Ulcer Care

NCT02818322

Diabetic Foot - Telemedical Monitoring

UNKNOWN NA

Wound Assessment Accuracy and Treatment Efficiency

NCT07261488

Wound - in Medical Care

COMPLETED

Tracking Wound Infection With Smartphone Technology

NCT02704897

Surgical Site Infection

COMPLETED NA

Efficiency of Negative Pression Therapy With Instillation in the Debridement of Wound

NCT03386175

Wound

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This trial conducted to assess the efficiency of teleconsultation using the smart-phone-based store-and-forward system in promoting the wound healing process as well as cost-effectiveness in patients with pressure ulcer.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pressure Ulcer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Telemedicine system

Group Type EXPERIMENTAL

Telemedicine system

Intervention Type DEVICE

The data such as photographs can be collected simply using built-in cameras installed in smart-phones that used the standard touch-screen user interface (UI) and camera installed in the iPhone3GS and iPhone4 using iOS 3.0 and iOS 5.0, respectively. Subjects were instructed to transmit the photographs of the wounds then investigator performed the photography in such a manner that the size of pressure ulcer should be automatically measured based on a 1 cm x 1 cm-sized indicator on the screen.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telemedicine system

The data such as photographs can be collected simply using built-in cameras installed in smart-phones that used the standard touch-screen user interface (UI) and camera installed in the iPhone3GS and iPhone4 using iOS 3.0 and iOS 5.0, respectively. Subjects were instructed to transmit the photographs of the wounds then investigator performed the photography in such a manner that the size of pressure ulcer should be automatically measured based on a 1 cm x 1 cm-sized indicator on the screen.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects who have pressure ulcer
* Subjects who voluntarily decided the participation of the study and signed the informed consent

Exclusion Criteria

* Subjects who have Osteomyelitis
* Subjects who have suppuration
* Subjects who participated in other clinical trial within 30 days from screening date

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No